The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $2.09

Today's change0.00 0.00%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX
Last

(U.S.) $2.09

Today's change0.00 0.00%
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc closed at (U.S.)$2.09.

Over the last five days, shares have gained 0.48% and 72.73% year to date. Shares have underperformed the S&P 500 by 86.50% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.09
  • High--
  • Low--
  • Bid / Ask(U.S.) $1.34 / (U.S.) $2.35
  • YTD % change+72.73%
  • Volume0
  • Average volume (10-day)205,802
  • Average volume (1-month)350,479
  • Average volume (3-month)433,147
  • 52-week range(U.S.) $0.80 to (U.S.) $8.35
  • Beta-0.76
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.90
Updated September 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4567
Selling / general / administrative2252
Research & development3315
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-4-5-6-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-5-6-7
Income after tax-4-5-6-7
Income tax, total--------
Net income-4-5-6-7
Total adjustments to net income--------
Net income before extra. items-4-5-6-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-5-6-7
Inc. avail. to common incl. extra. items-4-5-6-7
Diluted net income-4-5-6-7
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.18-0.20-0.26-0.27
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.18-0.20-0.26-0.27